For investors
The physical layer of robotics 2.0.
AI is moving fast. Hardware is the bottleneck. MYONEX LAB builds biomimetic artificial muscles — the physical layer that lets robots move with the compliance, sensing, and efficiency of living tissue.
01. Market opportunity
A market built for compliant actuation.
Target Market Mix (2033)
- Robotics 45%
- Prosthetics 25%
- Exoskeletons 20%
- Components 10%
Market Volumes by Vertical (2033)
02. Revenue streams
Hardware, modules, IP, and products.
Component Sales
Sarcomites and fibrils sold as building blocks to OEMs and research labs.
Integrated Muscle Modules
Ready-to-integrate actuation units with sensing, force, and control interfaces.
Licensing & IP
Architecture, materials, and integration methods licensed into partner platforms.
Application Products
Selected end products in prosthetics, robotics, and exoskeletons where we own the stack.
Revenue Mix Outlook
- Components 32%
- Modules 28%
- Licensing & IP 22%
- Products 18%
03. Why MYONEX LAB can win
Built to beat motor-driven actuation.
Capability
MYONEX LAB Artificial Muscle
Conventional Motor-Driven
Soft & adaptive
Built-in sensing
Energy efficiency
Force density
Human-like compliance
Scalable architecture
04. Why this technology will be top
Actuation that senses. A platform that scales.
Actuation + Sensing
Force and feedback live in the same fiber. No extra sensor stack to bolt on later.
Biomimetic compliance
Machines can yield, recover, and stay safe around people without heavy control hacks.
Platform use
The same architecture serves robotics, prosthetics, and exoskeletons from day one.
Early technical proof points
2%
Contraction
Measured fiber-level response in early prototypes.
10–40 μm
Precision
Position control at the sarcomite scale.
Partner with us
Invest in the next actuation platform.
We work with investors who want to own the physical layer of robotics — not another software wrapper on yesterday’s motors.
Request Investor Materials